Skip to main content
MCK
NYSE Life Sciences

McKesson Q1 Beats, Raises FY27 EPS View to $45 High-End

Tom Rudovsky · Reported by Reuters
More coverage: Consumer
Sentiment info
Positive
Importance info
9
Price
$880
Mkt Cap
$102.704B
52W Low
$637
52W High
$999
52W Position info
38% above low
Off High info
12% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

MCK sits 38% above its 52-week low of $637.

Summary

McKesson delivered a strong fiscal Q1, with revenue of $105.38B and adjusted EPS of $9.93, both comfortably ahead of consensus. The company raised its full-year adjusted EPS guidance to $44.20-$45.00, implying 13-15% growth, and boosted the quarterly dividend by 15%. Despite the strong adjusted results, the company revealed a fall in Q1 bottom line on a GAAP basis. Growth was driven by higher prescription volumes and specialty product distribution in the North American Pharmaceutical and Oncology segments. This follows the robust FY26 results and $7.7B buyback authorization announced in May, reinforcing the positive trajectory. The raised outlook and capital returns signal management's confidence in sustained momentum.

Updates

  1. · SEC 10-Q — The 10-Q shows GAAP net income attributable to McKesson of $614M, diluted EPS of $5.15, and $136M in restructuring charges. Apollo Funds acquired a 13% stake in Medical-Surgical Solutions for $1.25B on June 1, 2026.

At the time of this announcement, MCK was trading at $880.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $102.7B. The 52-week trading range was $637.00 to $999.00. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

MCK - Latest Insights

MCK
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1,049.50
Real-time Price: $1,055.55 info
Change: +$6.05 (+0.58%) info
Market Cap: $122.633B info
MCK
Nov 04, 2026, 5:30 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1,060.30
Real-time Price: $1,055.55 info
Change: -$4.75 (-0.45%) info
Market Cap: $122.633B info
MCK
Nov 04, 2026, 4:10 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $1,069.44
Real-time Price: $1,055.55 info
Change: -$13.89 (-1%) info
Market Cap: $122.633B info
MCK
Oct 06, 2026, 8:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $915.45
Real-time Price: $1,055.55 info
Change: +$140.10 (+15%) info
Market Cap: $122.633B info
MCK
Oct 05, 2026, 4:03 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $915.96
Real-time Price: $1,055.55 info
Change: +$139.59 (+15%) info
Market Cap: $122.633B info